Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Aakaar Medical TechnologiesNSE:AAKAAR +0.17%20 Return-on-Tangible-Asset is 19.79% as of Mar. 2026, which is 97% above its 10-year median of 10.03. GuruFocus rates NSE:AAKAAR with a GF Score™ of 20/100. The stock has 3 warning signs investors should review. Among 855 Medical Devices & Instruments companies, Aakaar Medical Technologies ranks better than 81.75% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Aakaar Medical Technologies's annualizedNet Income for the quarter that ended in Mar. 2026 was ₹148.4 Mil. Aakaar Medical Technologies's average total tangible assets for the quarter that ended in Mar. 2026 was ₹750.2 Mil. Therefore, Aakaar Medical Technologies's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2026 was 19.79%.
The historical rank and industry rank for Aakaar Medical Technologies's Return-on-Tangible-Asset or its related term are showing as below:
NSE:AAKAAR'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 8.99 Med: 10.03 Max: 13.69
Current: 9.75
During the past 5 years, Aakaar Medical Technologies's highest Return-on-Tangible-Asset was 13.69%. The lowest was 8.99%. And the median was 10.03%.
NSE:AAKAAR's Return-on-Tangible-Asset is ranked better than 81.75% of 855
companies
in the Medical Devices & Instruments industry
Industry Median: 0.74
vs NSE:AAKAAR: 9.75
Aakaar Medical Technologies (NSE:AAKAAR) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Aakaar Medical Technologies Return-on-Tangible-Asset Related Terms
Aakaar Medical Technologies Return-on-Tangible-Asset Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aakaar Medical Technologies Return-on-Tangible-Asset Chart
NSE:AAKAAR vs ABT, SYK, MDT: Return-on-Tangible-Asset Comparison
For the Medical Devices subindustry, Aakaar Medical Technologies's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aakaar Medical Technologies Return-on-Tangible-Asset vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Aakaar Medical Technologies's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Aakaar Medical Technologies's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is two times the semi-annual (Mar. 2026) net income data.
What does a Return-on-Tangible-Asset of 19.79% mean?
Aakaar Medical Technologies (NSE:AAKAAR) has a Return-on-Tangible-Asset of 19.79% as of Mar. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Aakaar Medical Technologies and its competitors. This is 97% above median its historical median of 10.03. Over the past decade, Aakaar Medical Technologies' Return-on-Tangible-Asset has ranged from 8.99 to 13.69. According to the industry distribution chart, Aakaar Medical Technologies ranks #156 out of 855 companies in the Medical Devices & Instruments industry, placing it in the top 18.2%.
Is Aakaar Medical Technologies' Return-on-Tangible-Asset too high?
Aakaar Medical Technologies' current Return-on-Tangible-Asset of 19.79% is 97% above median its 10-year median of 10.03. Over the past 10 years, this metric has ranged from a low of 8.99 to a high of 13.69. The Medical Devices & Instruments industry median Return-on-Tangible-Asset is 0.74. Aakaar Medical Technologies' value of 19.79% is 2574.3% above this industry median. Based on the distribution chart, Aakaar Medical Technologies ranks #156 out of 855 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Aakaar Medical Technologies has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Aakaar Medical Technologies' Return-on-Tangible-Asset compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Aakaar Medical Technologies ranks #156 out of 855 companies for Return-on-Tangible-Asset. This places Aakaar Medical Technologies in the top 18% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Asset is 0.74. Aakaar Medical Technologies' value of 19.79% is 2574.3% above this benchmark. Historically, Aakaar Medical Technologies' own Return-on-Tangible-Asset has ranged from 8.99 to 13.69 over the past decade. While the company's 10-year median is 10.03 vs. the industry median of 0.74, Aakaar Medical Technologies has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Medical Devices & Instruments company?
The median Return-on-Tangible-Asset among Medical Devices & Instruments companies is 0.74, based on 855 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aakaar Medical Technologies's current Return-on-Tangible-Asset of 19.79% is 2574.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Aakaar Medical Technologies and its competitors. For the Medical Devices & Instruments industry, the median Return-on-Tangible-Asset is 0.74 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aakaar Medical Technologies's current Return-on-Tangible-Asset is 19.79%, which is 97% above median its own 10-year median of 10.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aakaar Medical Technologies stock overvalued right now?
Aakaar Medical Technologies (NSE:AAKAAR) has a current Return-on-Tangible-Asset of 19.79%. The current Return-on-Tangible-Asset is 19.79%, which is 97% above median its 10-year median of 10.03 and 2574.3% above the Medical Devices & Instruments industry median of 0.74. Aakaar Medical Technologies' overall GF Score™ is 20/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Aakaar Medical Technologies (NSE:AAKAAR), the current Return-on-Tangible-Asset is 19.79% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Aakaar Medical Technologies Ltd is a medical aesthetic company dealing in a wide range of aesthetics & specialized cosmetic products & devices. Its product range includes both Own brands (domestically manufactured products & internationally manufactured devices) and Imported Brands (distribution of imported brands) from countries such as Korea, Spain, Italy, and Austria. It has established a distinctive presence in the medical aesthetic market by exclusively focusing on business-to-business(B2B) channels for product distribution and sales. The company supply its products & devices to dermatologists, plastic surgeons, aesthetic physicians who then sell these products to their end consumers as well as use certain device consumables as part of their treatments.
20GF Score
Get the complete analysis for NSE:AAKAAR
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:AAKAAR has been successfully added to your 
